2C-I-FLY
(重新導向自C12H14INO2)
| File:2C-I-FLY.svg | |
| 臨床資料 | |
|---|---|
| 藥物類別 | Serotonergic psychedelic; Hallucinogen |
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 1354633-88-7 |
| PubChem CID | |
| E編碼 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤:attempt to index field 'wikibase' (a nil value) |
| 化學資訊 | |
| 化學式 | C12H14INO2 |
| 摩爾質量 | 331.15 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
2C-I-FLY(化學名:2-(4-碘-2,3,6,7-四氫呋喃並[2,3-f][1]苯並呋喃-8-基)乙胺[1])是一種具有苯乙胺結構的迷幻藥物,是一種單胺氧化酶A抑制劑(IC50 = 13 μM)。[2]它可引起齧齒動物的頭部抽搐反應,這符合迷幻藥作用的行為學指標。[3]
參考文獻[編輯]
- ^ Lea Wagmann; et al. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings. Drug Testing and Analysis, 2019. 11 (10): 1507-1521. doi:10.1002/dta.2675.
- ^ Wagmann L, Brandt SD, Stratford A, Maurer HH, Meyer MR. Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases (PDF). Drug Testing and Analysis. February 2019, 11 (2): 318–324 [2026-03-17]. PMID 30188017. doi:10.1002/dta.2494. (原始內容存檔 (PDF)於2024-11-09).
- ^ Halberstadt AL, Chatha M, Stratford A, Grill M, Brandt SD. Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs. Neuropharmacology. January 2019, 144: 368–376. PMC 6863604 可免費查閱. PMID 30385253. doi:10.1016/j.neuropharm.2018.10.037.